Transforming growth factor-β expression in otitis media with effusion

Laryngoscope

Volumn 108, Issue 7, 1998, Pages 1066-1070

  Cooter, Michael S ^a   Eisma, Roselle J ^a   Burleson, Joseph A ^a   Leonard, Gerald ^a   Lafreniere, Denis ^a   Kreutzer, Donald L ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Middle ear effusion; Otitis media with effusion; Pediatric age group; Transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; INFANT; MALE; MIDDLE EAR EFFUSION; MUCOID OTITIS MEDIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECRETORY OTITIS MEDIA; SEROUS OTITIS MEDIA; TYMPANOSTOMY TUBE;

CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; INFANT; ISOMERISM; MALE; MIDDLE EAR VENTILATION; OTITIS MEDIA WITH EFFUSION; OTITIS MEDIA, SUPPURATIVE; RECURRENCE; RISK FACTORS; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031746630     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199807000-00021     Document Type: Article

References (15)

1. Wright CG, Meyerhoff WL. Pathology of otitis media. Ann Otol Rhinol Laryngol Suppl 1994;163:24-6.
2. Mogi G, Bernstein JM. Immune mechanisms in otitis media with effusion. In Bernstein JM, Ogra PL, eds. Immunology of the Ear. New York: Raven Press; 1987.
3. Yellon R, Leonard G, Marucha P, et al. Characterization of cytokines present in middle ear effusions. Laryngoscope 1991;101:165-9.
4. Wahl S. Transforming growth factor beta (TGFb) in inflammation: a cause and a cure. J Clin Immunol 1992;12: 61-74.
5. Cohen J, Cohen P. Applied Multiple Regression/ Correlation Analysis for the Behavioral Sciences. New Jersey: Lawrence Erlbaum Associates; 1983.
6. Yoon TH, Paparella MM, Schachern PA, Lindgren BR. Morphometric studies of the continuum of otitis media. Ann Otol Rhinol Laryngol 1990;99:23-7.
7. Lim DJ, DeMaria TF. Panel discussion: pathogenesis of otitis media. Bacteriology and immunology. Laryngoscope 1982; 92:278-86.
8. Kuby J. Cytokines. In: Stewart MW, ed. Immunology. New York: WH Freeman and Co; 1991:297-322.
9. Border WA, Noble NA. TGFb in tissue fibrosis. N Engl J Med 1994;331(19):1286-92.
10. Massague J. The TGFb family. Ann Rev Cell Biol 1990;6: 597-611.
11. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995;108:985-1002.
12. Eisma RJ, Allen JS, Lafreniere D, Leonard G, Kreutzer DL. Enhanced expression of TGFb and its receptors in nasal polyposis: role of the eosinophil. Am J Otolaryngol 1997;18(6):405-11.
13. Koutnouyan HA, Baird A, Ryan AF. Acidic and basic FGF mRNA expression in the middle ear mucosa during experimental acute and chronic otitis media. Laryngoscope 1994;104:350-8.
14. Marenda SA, Aufdemorte TB. Localization of cytokines in cholesteatoma tissue. Otolaryngol Head Neck Surg 1995; 112(3):359-68.
15. Ramsay HA, Heikkonen EJ, Laurila PK. Effect of epidermal growth factor on tympanic membranes with chronic perforations: a clinical trial. Otolaryngol Head Neck Surg 1995; 113(4):375-9.